Limb Regeneration – From Salamanders to Humans, The Science Is Getting Closer
Audio Overview
Limb Regeneration – From Salamanders to Humans, The Science Is Getting Closer
View Transcript
New research published in Nature Communications brings us significantly closer to answering that question—and the findings suggest human limb regeneration may be more achievable than we thought.
The key is a molecule called retinoic acid and an enzyme called CYP26B1. Retinoic acid acts like a GPS system for regenerating cells, telling them their position in the body. The concentration gradient—more near the shoulder, less near the hand—guides cells to know exactly what structures to rebuild.
CYP26B1 is the enzyme that breaks down retinoic acid, controlling this gradient. In salamanders called axolotls, this system works beautifully: after amputation, cells dedifferentiate—reverting to a stem-cell-like state—and then follow the retinoic acid signals to rebuild exactly the right structures.
Here’s what’s remarkable: humans have the CYP26B1 enzyme too. We have essentially the same molecular machinery. When researchers removed the gene for a related signaling molecule in axolotls using CRISPR, the animals grew very short arms with normal-sized hands—exactly the same pattern seen in humans with mutations in that gene.
So why can’t we regenerate limbs? The current understanding is that our cells don’t dedifferentiate when injured. Instead of responding to regeneration signals, human tissues form scars.
This suggests the barrier to human regeneration might be removing the block on dedifferentiation rather than adding entirely new capabilities. As one researcher put it: “Maybe we don’t need to add genes or remove genes to induce regeneration in humans—we can just turn on the appropriate genes at the right time.”
We’re still years from regrowing human limbs. But understanding the molecular blueprint is the essential first step.
The Salamander Mystery
Axolotls—a species of salamander native to Mexico—can do something humans cannot. When an axolotl loses a limb, it grows back. Completely. Bone, muscle, nerves, blood vessels, skin—all regenerate to form a fully functional replacement. They can even regenerate parts of their heart, spine, and brain.
For scientists studying regenerative medicine, this capability has been both inspiring and frustrating. Inspiring because it demonstrates that complex limb regeneration is biologically possible. Frustrating because despite decades of research, the mechanisms have remained elusive enough to prevent translation to humans.
New research brings us closer to understanding exactly how axolotl regeneration works—and suggests that the gap between salamander capability and human limitation may be smaller than we thought.
The Retinoic Acid GPS
A study published in Nature Communications by Timothy Duerr, James Monaghan, and colleagues reveals that retinoic acid—a derivative of vitamin A that plays numerous roles in development—functions as a positional guidance system during limb regeneration.
When an axolotl limb is amputated, cells at the wound site dedifferentiate, reverting from their specialized states back to a more stem-cell-like condition. These dedifferentiated cells form a structure called a blastema—a mound of regeneration-competent cells that will rebuild the limb.
But how do cells in the blastema know what to become? How do they know whether they’re rebuilding an upper arm, forearm, or hand?
The answer involves concentration gradients of retinoic acid. The researchers found that axolotls have higher retinoic acid levels near the body center (shoulder region) and lower levels distally (toward the hand). This gradient tells regenerating cells their position: high retinoic acid means “you’re near the shoulder, build proximal structures,” while low retinoic acid means “you’re far from the body, build hand structures.”
The Enzyme That Controls It
Critical to maintaining this gradient is an enzyme called CYP26B1. This enzyme breaks down retinoic acid, and its activity creates the concentration differences that regenerating cells read as positional information.
The researchers demonstrated this by manipulating CYP26B1 levels and observing the effects on regeneration. Disrupting the enzyme’s normal function disrupted the gradient, and with it, the positional guidance that produces correctly proportioned limbs.
Here’s where the research becomes particularly relevant to human medicine: CYP26B1 isn’t unique to salamanders. Humans have this enzyme too. We share the same basic molecular machinery for retinoic acid signaling.
The SHOX Connection
To test how conserved these mechanisms are between salamanders and humans, researchers used CRISPR gene editing to disable a gene called shox (short stature homeobox) in axolotls. This gene is activated by retinoic acid signaling and influences limb proportions.
The result: axolotls with disabled shox grew limbs with very short proximal segments (upper arm and forearm) but normal-sized hands. This is exactly the pattern seen in humans with SHOX mutations, who have a condition called LĂ©ri-Weill syndrome characterized by short forearms and short lower legs with relatively normal hands and feet.
This striking parallel suggests that the regulatory pathways controlling limb proportions are deeply conserved between salamanders and humans. The machinery is shared—even if the outcomes of injury differ dramatically.
Why Can’t Humans Regenerate?
If humans have the same enzymes and similar genetic pathways, why don’t we regenerate limbs?
The current understanding focuses on what happens immediately after injury. In salamanders, cells adjacent to the wound dedifferentiate—they lose their specialized identity and become capable of forming new tissue types. This is the foundation of regeneration.
Human cells don’t do this. When injured, human tissues respond with scar formation. Fibroblasts lay down collagen to close the wound, but they don’t revert to a stem-like state capable of rebuilding complex structures. The wound heals, but as a scar rather than regenerated tissue.
This suggests that the fundamental capability for regeneration isn’t absent in humans—it’s blocked. The signaling pathways exist. The positional information systems exist. What’s missing is the ability of mature cells to respond by dedifferentiating.
Implications for Medicine
This reframing—from “humans lack regeneration machinery” to “human regeneration is blocked”—has significant therapeutic implications.
If regeneration requires adding capabilities we don’t have, the challenge is enormous. Gene therapy to add salamander-specific genes would face daunting safety and efficacy hurdles.
But if regeneration requires removing a block on existing capabilities, the challenge changes character. As one researcher on the study noted: “Maybe we don’t need to add genes or remove genes to induce regeneration in humans—we can just turn on the appropriate genes at the right time or turn off the appropriate genes at the right time.”
This perspective aligns with other recent findings showing that mammalian cells retain surprising plasticity under the right conditions. Partial reprogramming approaches have demonstrated that mature cells can be pushed toward more youthful states without full dedifferentiation.
Practical Hurdles
Understanding the science is necessary but not sufficient for clinical application. Significant challenges remain.
Even if dedifferentiation could be induced in human wounds, the timeline would be daunting. Axolotls regrow tiny limbs in days to weeks. A human limb would require regenerating vastly more tissue over what could be years. Maintaining the regenerative process, ensuring proper nerve and blood vessel integration, and preventing tumor formation during extended regeneration would all present challenges.
The immune system complicates matters further. In salamanders, the immune response appears compatible with regeneration. In humans, inflammatory responses to injury may actively suppress regenerative pathways.
And practical considerations abound. A regrowing limb would presumably need to be protected, supplied with nutrients, and somehow kept functional during an extended regeneration process. The logistics boggle imagination.
Steps Forward
Despite these hurdles, the research provides a clearer roadmap than existed before.
Understanding that retinoic acid gradients guide positional identity during regeneration suggests potential intervention points. Researchers can now investigate whether similar signaling occurs in human wound healing and what blocks the regenerative response.
The SHOX findings demonstrate that axolotls can serve as a model for human limb development and disease. Insights from salamander studies may translate more directly than previously appreciated.
And the observation that human regeneration may be blocked rather than absent opens the possibility of unblocking approaches—potentially through drugs or transient gene therapies rather than permanent genetic modifications.
The Longer View
Limb regeneration in humans remains distant. Timothy Duerr, a lead researcher on the study, was appropriately measured: “Limb regeneration [in humans] is still a ways away, but I think we’ve definitely uncovered an important aspect of it.”
But the trajectory of the science is encouraging. Researchers have moved from wondering whether human regeneration is theoretically possible to understanding specific molecular pathways that might enable it.
Each discovery narrows the gap between what salamanders can do and what humans might eventually achieve. The question has shifted from “why can’t humans regenerate?” to “what specifically prevents human regeneration, and can we address it?”
For the millions of people who have lost limbs to trauma, disease, or military service, this research represents progress toward a future that once seemed like science fiction—a future where the body might rebuild what was lost.
Sources
1. Duerr TJ, Monaghan JR, et al. “Retinoic acid breakdown is required for proximodistal positional identity during axolotl limb regeneration.” Nature Communications. 2025. https://www.nature.com/articles/s41467-025-59497-5
2. Northeastern University News. “How do axolotls regenerate limbs and organs? This researcher has started to uncover the secret.” June 2025. https://news.northeastern.edu/2025/06/10/axolotl-limb-regeneration/
3. SUNY Cortland. “Biology alum leads groundbreaking research on limb regrowth.” 2025. https://www2.cortland.edu/news/duerr-limb-regeneration
